VIVUS, Inc., founded in Campbell, California, is a biopharmaceutical company focused on developing therapies for obesity, sleep apnea, diabetes, and sexual health. The company aims to improve patient quality of life by addressing serious medical conditions and life-limiting diseases. VIVUS offers products such as PANCREAZE for Exocrine Pancreatic Insufficiency (EPI) and Stendra, an FDA-approved erectile dysfunction drug that can be taken 15 minutes before sexual activity.
Notable figures associated with VIVUS include its experienced clinical development and commercialization team. The company has achieved significant milestones, including the FDA approval of Stendra and the successful commercialization of PANCREAZE. VIVUS's impact is marked by its commitment to enhancing therapeutic options and improving health outcomes for patients with chronic and serious conditions.
